Hospital News and Research

RSS

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

NovaBay Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing a new class of anti-infectives for treating multi-drug resistant pathogens, announced today that it has received $3.75 million in milestone payments from partner Galderma S.A.

11 Jan 2010

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts announced today that Catholic Health Initiatives (CHI) has selected the Allscripts Electronic Health Record (EHR) solution for its 1050 employed physicians to enhance the quality of patient care, improve communications, and deliver more cost-effective care.

11 Jan 2010

Allscripts Care Management solution selected for Legacy Health's hospitals

Allscripts announced today that Legacy Health has selected the Allscripts Care Management solution for its six hospitals and two post-acute care facilities, helping to manage and coordinate care for the 90,000 patients it serves each year.

11 Jan 2010

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Cardiac Science Corporation, a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, has joined with Gust Bardy, MD to create an innovation center focused on the development and commercialization of simple, cost-effective medical products and services that positively impact public health.

11 Jan 2010

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

The INSTITUT CURIE and IPSOGEN (FR0010626028 - ALIPS) announce the signing of a scientific collaboration agreement in the breast cancer domain. Within the framework of this project, the current scientific knowledge on Ipsogen's MapQuant Dx Grade Genomic, HER2 and HR tests will be increased thanks to new data established from a large population of patients treated at the Institut Curie.

11 Jan 2010

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

KaloBios Pharmaceuticals, Inc. today announced an agreement with Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, for the development and commercialization of KB001, an investigational new biologic for the treatment or prevention of Pseudomonas aeruginosa (Pa) infections. Sanofi Pasteur will be responsible for the development and commercialization of KB001 and initially focus on hospital indications, including the prevention of Pa pneumonias in mechanically ventilated patients.

11 Jan 2010

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

Ask anyone who suffers from migraine headaches what they do when they're having an attack, and you're likely to hear "go into a dark room." And although it's long been known that light makes migraines worse, the reason why has been unclear.

11 Jan 2010

Autism spectrum disorders result from miswiring of connections in developing brain

Studying a rare disorder known as tuberous sclerosis complex (TSC), researchers at Children's Hospital Boston add to a growing body of evidence suggesting that autism spectrum disorders, which affect 25 to 50 percent of TSC patients, result from a miswiring of connections in the developing brain, leading to improper information flow.

10 Jan 2010

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

AMAG Pharmaceuticals, Inc. today provided an update on the commercial launch of Feraheme® (ferumoxytol) Injection for intravenous (IV) use, including preliminary fourth quarter 2009 Feraheme net product revenues estimates, as well as an update on the Company’s international and label expansion efforts.

10 Jan 2010

Quidel to acquire Diagnostic Hybrids for $130M

Quidel Corporation, a leading provider of rapid point-of-care diagnostic tests, announced today the signing of a definitive agreement to acquire privately held Diagnostic Hybrids, Inc. for approximately $130 million in cash.

10 Jan 2010

Thirteen percent of poison exposure calls related to painkillers

U.S. poison centers answered more than 4.3 million calls in 2008, including nearly 2.5 million calls about human exposures to poison, according to the American Association of Poison Control Centers -- up from 4.2 million calls in 2007.

9 Jan 2010

SEIU-UHW members call for NLRB to schedule elections early

Healthcare workers at 26 California hospitals and nursing homes are seeking elections to join more than 55,000 other union members who have already chosen to stay united in the Service Employees International Union - United Healthcare Workers West (SEIU-UHW), rather than switch to an organization formed by the union's ousted leaders.

9 Jan 2010

Clinical Foundations' edition provides comprehensive review of hospital-acquired infections

Clinical Foundations, a patient-focused education program dedicated to helping respiratory care professionals stay current on clinical trends, has recently published a new edition titled “Pathogens Associated with the Intensive Care Unit Environment –Considerations for the Respiratory Therapist.”

9 Jan 2010

Gilbert Hospital remains one of the best choices for hospital care in the southeast valley

Gilbert Hospital continued to exceed expectations in 2009. With more than 43,190 patient visits through the emergency department, patient levels remained constant compared to 2008.

9 Jan 2010

LehmanMillet adds two new accounts: Myriad Genetics and Breathe Technologies

HealthSTAR's LehmanMillet, the leading agency devoted to working with health care companies changing standards of care, today announced the addition of two new accounts: Myriad Genetics and Breathe Technologies.

9 Jan 2010

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

Following the sudden death yesterday of the former French government minister Philippe Séguin, who suffered a fatal heart attack, aged 66, the European Society of Cardiology is warning the public of the dangers of leaving risk factors such as hyperlipidemia, hypertension or diabetes untreated. Other major risk factors for coronary artery disease are smoking or being overweight.

9 Jan 2010

EGS announces improved clinical outcomes from its new TIF procedure

EndoGastric Solutions (EGS), the recognized leader in the emerging field of Natural Orifice Surgery (NOS), today announced that data from two single-center series demonstrate improved clinical outcomes from a third-generation technique for its Transoral Incisionless Fundoplication (TIF) procedure. The data includes two case series totaling nearly 70 patients from two independent investigators, Reginald Bell, MD (Swedish Medical Center, Englewood, CO), and William Barnes, MD (Livingston Hospital and Healthcare Services, Inc., Salem, KY).

9 Jan 2010

Apollo Health Street launches two service lines to expand hospital revenue cycle management solutions

Apollo Health Street, a developer of world-class solutions that tackle healthcare’s toughest financial and IT challenges, is expanding their hospital revenue cycle management solutions by launching two service lines to help providers recover revenue they are due from denied and zero balance claims.

9 Jan 2010

Origin Healthcare Solutions: TCV makes substantial growth equity investment

Origin Healthcare Solutions (“Origin” or the “Company”), an industry leader in healthcare revenue cycle management services and business and clinical intelligence systems, announced that Technology Crossover Ventures (“TCV”) has made a significant growth equity investment in the Company.

9 Jan 2010

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Acetylon Pharmaceuticals, Inc. announced today that it has closed on a $2 million investment from a new undisclosed private investor to bring its total financing to $9.25 million. This new investment will convert to stock in the next substantial round of preferred equity financing.

9 Jan 2010

Hospital News and Research

Galderma S.A. offers $3.75 million to NovaBay Pharmaceuticals

CHI selects Allscripts' EHR solution to enhance patient care

Allscripts Care Management solution selected for Legacy Health's hospitals

Cardiac Science and Gust Bardy launch innovation center to develop cost-effective medical products and services

Institut Curie, Ipsogen sign scientific collaboration agreement in breast cancer domain

KaloBios Pharmaceuticals, Sanofi Pasteur partner in development of KB001 biologic for Pa infections

BIDMC scientists identify new pathway to address the problem of photophobia during migraines

Autism spectrum disorders result from miswiring of connections in developing brain

AMAG Pharmaceuticals provides update on the commercial launch of Feraheme Injection

Quidel to acquire Diagnostic Hybrids for $130M

Thirteen percent of poison exposure calls related to painkillers

SEIU-UHW members call for NLRB to schedule elections early

Clinical Foundations' edition provides comprehensive review of hospital-acquired infections

Gilbert Hospital remains one of the best choices for hospital care in the southeast valley

LehmanMillet adds two new accounts: Myriad Genetics and Breathe Technologies

European Society of Cardiology warns public about risk factors involved in obesity, diabetes and hypertension

EGS announces improved clinical outcomes from its new TIF procedure

Apollo Health Street launches two service lines to expand hospital revenue cycle management solutions

Origin Healthcare Solutions: TCV makes substantial growth equity investment

Acetylon Pharmaceuticals to utilise additional funding in multiple myeloma drug development

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest News